| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.081 | 0.2 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.081 | 0.2 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |